BORTEZOMIB

Product NDC
0409-1703
11-digit product format
004091703
Labeler code
0409
Product ID
0409-1703_e7c31651-e301-43f9-bc81-e0fd5dcb828c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
BORTEZOMIB
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Labeler
Hospira, Inc.
Application
NDA209191
Marketing category
NDA
Marketing start
2022-05-16
Substance
BORTEZOMIB
Active strength
2.5 mg/1
Pharmacologic classes
Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
BORTEZOMIB
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BORTEZOMIB2.5 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii69G8BD63PP
Rxcui2601542, 2601544

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b069d653-565d-b331-cf82-116aa266aee9Product name420260317
987023d7-918d-4465-be3c-f3f8f784679bProduct name120250318
2cff6375-aa9a-4194-a1db-33f6ed6564f1Product name120230322
f8ade071-6be1-4cb3-a390-e8ba41353f9bProduct name120230322
c3c5823c-3bc3-46c2-bc6a-295b30affa78Product name120230113
6429b384-c989-4e27-bc69-c5e1c7dc2e31Product name120200304
71c1111b-030c-4ada-94cb-bf623cfad8ecProduct name120180108

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0409-1703-01BORTEZOMIB1 in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,13
0409-1703-01BORTEZOMIB1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,13

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0409-1703-01EA - Each0409-1703bb3beaf3-ee68-4507-a25f-427730537fa612022-06-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0409-1703BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.]3Current NDC, Legacy NDC, 2 package rows20230308_9fdf6169-699f-40eb-bda1-760253062b3c.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2601542bortezomib 1 MG InjectionPSN9fdf6169-699f-40eb-bda1-760253062b3c3
2601544bortezomib 2.5 MG InjectionPSN9fdf6169-699f-40eb-bda1-760253062b3c3
2601542bortezomib 1 MG InjectionSCD9fdf6169-699f-40eb-bda1-760253062b3c3
2601544bortezomib 2.5 MG InjectionSCD9fdf6169-699f-40eb-bda1-760253062b3c3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0409-1703-01004091703011 VIAL, SINGLE-DOSE in 1 CARTON (0409-1703-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE2022-05-160000-00-00NoNoCurrent